Company profile

MagCyte company profile

MAGCYTE is breaching the frontier in cancer detection. By detecting the Circulating Tumor Cells (CTCs) responsible for tumor metastasis, right in the beginning of the tumor growth, it is possible to diagnose cancer up to 4 years before it is detectable with imaging techniques, and to eliminate the tumor in an early stage. MAGCYTE does this by filtering CTCs from blood samples, marking them with cancer-seeking immuno-magnetic markers and analyzing them with its state-of-art integrated magnetic sensors. By entering the fast-growing market of CTC technology with our unique combination of microfluidics, microelectronics and magnetic sensors, MAGCYTE will be able to..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Phone number
+351 967 321 255
Operating status
Active
Company type
For Profit

Headquarters

Headquarters
Neuhof, Warmia-Masuria, Poland
Postal code
1000-029
Country code
PL
Continent
Europe

Capital profile

Funding and company signals

No public funding data is available for this company.

Categories and groups

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.